Fibrate use in diabetes: new concepts.

Hanna Bloomfield Rubins, Sander J. Robins, Dorothea Collins, Carol L. Fye, James W. Anderson, Marshall B. Elam, Fred H. Faas, Esteban Linares, Ernst J. Schaefer, Gordon Schectman, Timothy J. Wilt, Janet Wittes, Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol The New England Journal of Medicine. ,vol. 341, pp. 410- 418 ,(1999) , 10.1056/NEJM199908053410604

Oluf PEDERSEN, Intensified multifactorial treatment of patients with Type 2 diabetes: what can be achieved and does it pay off? Journal of Diabetes. ,vol. 1, pp. 83- 89 ,(2009) , 10.1111/J.1753-0407.2009.00014.X

R. Scott, R. O'Brien, G. Fulcher, C. Pardy, M. d'Emden, D. Tse, M.-R. Taskinen, C. Ehnholm, A. Keech, , Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes Care. ,vol. 32, pp. 493- 498 ,(2009) , 10.2337/DC08-1543

R. S. Elkeles, J. R. Diamond, C. Poulter, S. Dhanjil, A. N. Nicolaides, S. Mahmood, W. Richmond, H. Mather, P. Sharp, M. D. Feher, , Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care. ,vol. 21, pp. 641- 648 ,(1998) , 10.2337/DIACARE.21.4.641

Nish Chaturvedi, Anne-Katrin Sjoelie, Massimo Porta, Steven J Aldington, John H Fuller, Marco Songini, Eva M Kohner, EURODIAB Prospective Complications Study Group, None, Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study Diabetes Care. ,vol. 24, pp. 284- 289 ,(2001) , 10.2337/DIACARE.24.2.284

R C Turner, H Millns, H A W Neil, I M Stratton, S E Manley, D R Matthews, R R Holman, Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ. ,vol. 316, pp. 823- 828 ,(1998) , 10.1136/BMJ.316.7134.823

A. Garg, S. M. Grundy, Management of Dyslipidemia in NIDDM Diabetes Care. ,vol. 13, pp. 153- 169 ,(1990) , 10.2337/DIACARE.13.2.153

P. Koskinen, M. Manttari, V. Manninen, J. K. Huttunen, O. P. Heinonen, M. H. Frick, Coronary heart disease incidence in NIDDM patients in the Helsinki heart study Diabetes Care. ,vol. 15, pp. 820- 825 ,(1992) , 10.2337/DIACARE.15.7.820

Jerrold M. Olefsky, John W. Farquhar, Gerald M. Reaven, Reappraisal of the role of insulin in hypertriglyceridemia The American Journal of Medicine. ,vol. 57, pp. 551- 560 ,(1974) , 10.1016/0002-9343(74)90006-0

G M Reaven, Y D Chen, J Jeppesen, P Maheux, R M Krauss, Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. Journal of Clinical Investigation. ,vol. 92, pp. 141- 146 ,(1993) , 10.1172/JCI116541